InvestorsHub Logo
Followers 4
Posts 372
Boards Moderated 0
Alias Born 08/13/2019

Re: marzan post# 229001

Wednesday, 11/20/2019 7:44:46 PM

Wednesday, November 20, 2019 7:44:46 PM

Post# of 425883

how could they legally patent the use of V in their combo patent without infringing the owner rights of Amarin? How could FDA approve such a cohort when found efficacious in the trial? How could GILD ensure they get a constant supply of V if they don't have an agreement with Amarin?



Patents grant applicants with the right to EXCLUDE, not a right to MAKE. You could submit a patent today using Vascepa, that if approved, would prevent Amarin from manufacturing your patented product. It's a strategy commonly employed by patent trolls. Of course, you would need Amarin's permission (usually through a licensing agreement) to use Vascepa to make your patented product.

As for a supply of Vascepa, they probably source it from a wholesaler like any other pharmacy, not necessarily through a partnership with Amarin.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News